Biden’s statement misses the mark because of messy math.
Caveat emptor. Some of these health insurance plans might prove helpful for some people, but making that determination is not easy.
A sampling of health policy highlights from the eighth Democratic presidential primary debate in Manchester, N.H.
In his Feb. 4 State of the Union address, President Donald Trump said the cost of extending health care to people regardless of their citizenship status would “bankrupt” the U.S.
We checked again. The data has not changed.
But like all of health care, it’s complicated.
This one is a big stretch.
Former New York City Mayor Michael Bloomberg uses health care as a key message in his Democratic presidential primary run.
The claim, which builds on previous statements and campaign messaging, drew strong reactions.
Democratic presidential candidates also returned to now-familiar themes in debating the differences between “Medicare for All” and more incremental reforms.
Calculations are complicated, but correct.
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
These numbers are stark.
‘Medication insecurity’ is a thing.
Candidates again sparred over “Medicare for All” and other approaches to health reform — but this time they waited more than two hours before wading into health policy issues.
The pharmaceutical industry’s argument that capping drug prices would compromise drug innovation stands “on very shaky ground.”
The term “vast” sets a high bar.
Former Vice President Joe Biden’s claim during the latest Democratic presidential debate relies on a squishy number, and the context matters.
Surgeon General Jerome Adams said the drug has a “unique impact” on the developing brain — technically true, but neglecting a vital comparison to other drugs, as well as shortcomings in the existing research.
Big picture remains hazy, but these numbers add up.